Impact of nucleoporin-mediated chromatin localization and nuclear architecture on HIV integration site selection

Journal of Virology

Volumn 89, Issue 19, 2015, Pages 9702-9705

  Wong, Richard W ^a   Mamede, João I ^b   Hope, Thomas J ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOPLASM PROTEIN; NUCLEOPORIN; PROTEIN NUP153; PROTEIN TPR; UNCLASSIFIED DRUG; CHROMATIN;

ARTICLE; CELL NUCLEUS; CHROMATIN; CHROMATIN STRUCTURE; CYTOPLASM; GENE ACTIVATION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DOCKING; NONHUMAN; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; ELECTRON MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; ULTRASTRUCTURE; VIRUS ATTACHMENT;

CELL NUCLEUS; CHROMATIN; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MICROSCOPY, ELECTRON; NUCLEAR PORE COMPLEX PROTEINS; VIRUS ATTACHMENT; VIRUS INTEGRATION;

EID: 84940980197     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01669-15     Document Type: Article

References (20)

1. Cohen S, Au S, Panté N. 2011. How viruses access the nucleus. Biochim Biophys Acta 1813:1634-1645. http://dx.doi.org/10.1016/j.bbamcr.2010.12.009.
2. Di Nunzio F. 2013. New insights in the role of nucleoporins: a bridge leading to concerted steps from HIV-1 nuclear entry until integration. Virus Res 178:187-196. http://dx.doi.org/10.1016/j.virusres.2013.09.003.
3. Hilditch L, Towers GJ. 2014. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr Opin Virol 4:32-36. http://dx.doi.org/10.1016/j.coviro.2013.11.003.
4. Matreyek KA, Engelman A. 2013. Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes. Viruses 5:2483-2511. http://dx.doi.org/10.3390/v5102483.
5. Lelek M, Casartelli N, Pellin D, Rizzi E, Souque P, Severgnini M, Di Serio C, Fricke T, Diaz-Griffero F, Zimmer C, Charneau P, Di Nunzio F. 2015. Chromatin organization at the nuclear pore favours HIV replication. Nat Commun 6:6483. http://dx.doi.org/10.1038/ncomms7483.
6. Marini B, Kertesz-Farkas A, Ali H, Lucic B, Lisek K, Manganaro L, Pongor S, Luzzati R, Recchia A, Mavilio F, Giacca M, Lusic M. 2015. Nuclear architecture dictates HIV-1 integration site selection. Nature 521: 227-231. http://dx.doi.org/10.1038/nature14226.
7. Strambio-De-Castillia C, Niepel M, Rout MP. 2010. The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol 11:490-501. http://dx.doi.org/10.1038/nrm2928.
8. Ibarra A, Hetzer MW. 2015. Nuclear pore proteins and the control of genome functions. Genes Dev 29:337-349. http://dx.doi.org/10.1101/gad.256495.114.
9. Cautain B, Hill R, de Pedro N, Link W. 2015. Components and regulation of nuclear transport processes. FEBS J 282:445-462. http://dx.doi.org/10.1111/febs.13163.
10. Blobel G. 1985. Gene gating: a hypothesis. Proc Natl Acad Sci U S A 82:8527-8529. http://dx.doi.org/10.1073/pnas.82.24.8527.
11. Hase ME, Cordes VC. 2003. Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex. Mol Biol Cell 14:1923-1940. http://dx.doi.org/10.1091/mbc. E02-09-0620.
12. Matreyek KA, Engelman A. 2011. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J Virol 85:7818-7827. http://dx.doi.org/10.1128/JVI.00325-11.
13. Mamede JI, Sitbon M, Battini J-L, Courgnaud V. 2013. Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. Retrovirology 10:77. http://dx.doi.org/10.1186/1742-4690-10-77.
14. Matreyek KA, Yücel SS, Li X, Engelman A. 2013. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog 9:e1003693. http://dx.doi.org/10.1371/journal.ppat.1003693.
15. Kobayashi A, Hashizume C, Dowaki T, Wong RW. 2015. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A. Cell Cycle 14:1447-1458. http://dx.doi.org/10.1080/15384101.2015.1021518.
16. Nakano H, Funasaka T, Hashizume C, Wong RW. 2010. Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. J Biol Chem 285: 10841-10849. http://dx.doi.org/10.1074/jbc. M110.105890.
17. Krull S, Dörries J, Boysen B, Reidenbach S, Magnius L, Norder H, Thyberg J, Cordes VC. 2010. Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion. EMBO J 29: 1659-1673. http://dx.doi.org/10.1038/emboj.2010.54.
18. Hulme AE, Kelley Z, Foley D, Hope TJ. 2015. Complementary assays reveal a low level of CA associated with viral complexes in the nuclei of HIV-1-infected cells. J Virol 89:5350-5361. http://dx.doi.org/10.1128/JVI.00476-15.
19. Lukic Z, Dharan A, Fricke T, Diaz-Griffero F, Campbell EM. 2014. HIV-1 uncoating is facilitated by dynein and kinesin 1. J Virol 88:13613-13625. http://dx.doi.org/10.1128/JVI.02219-14.
20. Attar N. 2015. Viral infection: tracking down HIV's hiding place. Nat Rev Microbiol 13:186-187. http://dx.doi.org/10.1038/nrmicro3466.